STZ Constellation Brands, Inc.
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It offers beer under the Corona Extra, Corona Familiar, Corona Sunbrew, Corona Light, Corona Non-Alcoholic, Corona Premier, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Spiked Aguas Frescas, Modelo Oro, Modelo Noche Especial, Victoria, Vicky Chamoy, and Pacifico brand names. The company also offers wine under the Sea Smoke, Schrader Cellars, Kim Crawford, Mount Veeder, Ruffino, My Favorite Neighbor, Robert Mondavi Winery, and The Prisoner Wine Company brand names; and spirits under the Casa Noble, High West, Mi CAMPO, and Nelson's Green Brier brand names. Additionally, it offers a spirit-based, ready-to-drink alcoholic beverage under the SpikedAde brand. It provides its products to wholesale distributors, retailers, and state alcohol beverage control agencies. Constellation Brands, Inc. was founded in 1945 and is headquartered in Rochester, New York.…
Industry Peers
Beverages - BrewersKey Statistics
About Constellation Brands (NYSE: STZ)
›
Constellation Brands (NYSE: STZ) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Beverages - Brewers industry, part of the Consumer Defensive sector, and reports about 9,400 employees.
The shares were at 141.44 USD on 19 November 2026, up 11.0% over 52 weeks. Its 52-week range is 110.60 USD to 168.60 USD: the price is 16.1% below the high and 27.9% above the low.
At a market capitalisation of 23.94B USD, it trades at 12.7 times trailing earnings and 11.7 times forward earnings. The median trailing P/E of its 19 largest Beverages - Brewers peers is 16.2, a discount of 22% for STZ. It pays a dividend yielding 2.87% (it pays out 37% of its earnings), against a median of 3.36% among the dividend payers in that peer group.
Constellation Brands reports return on equity of 20.9%, an operating margin of 32.8% and revenue up 6.1% year over year.
Its debt exceeds its cash by 10.22B USD, a debt-to-equity ratio of 1.39. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 23 analysts cover the stock, with an average rating of Buy; their mean price target of 153.43 USD is 8.5% above the current price. The next earnings report is expected on 7 January 2027.